Patent Assignment
Reel/Frame 054580/0104
Assignment of Assignor's Interest
Recorded: 2020-12-03
Pages: 2
Assignors
RABBANI, ELAZAR
Executed: 2017-06-26
DONEGAN, JAMES J.
Executed: 2017-06-26
DIAMOND, PAUL
Executed: 2017-06-26
Assignee
ENZO BIOCHEM, INC.
527 MADISON AVENUE, NEW YORK, NEW YORK, 10022
Covered Property
(1)
Sphingosine Pathway Modulating Compounds for the Treatment of Cancers
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
Release of Security Interest
Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
Assignment of Assignor's Interest
Jul 9, 2026
From: ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES, INC.; ENZO THERAPEUTICS, INC.
To: SERAPH BIOTECH CONSULTING, LLC
Reel/Frame 075219/0465 →